In The States – Page 239 – Weekly news about states

Georgia

Several final rules from the Board of Pharmacy effective May 3.

Final rule of the Board of Pharmacy amends regulations under GAC 480-11 to require a Class A balance with weights or electronic balance only if compounding on-site using components that must be weighed.
Final rule of the Board of Pharmacy adopts regulations under GAC 480-10 to require retail pharmacies with affiliates to file a disclosure statement annually by June 30.
Final rule of the Board of Pharmacy amends regulations under GAC 480-10 to provide an exception from the requirement for a combined retail/hospital pharmacy to maintain a separate prescription department and have a pharmacist on duty when open for business. The rule also allows a nursing supervisor access to the pharmacy.
Final rule of the Board of Pharmacy amends regulations under GAC 480-36 to remove provisions on the responsibility of the pharmacist on duty at the primary dispensing pharmacy to assure the accuracy of remote entry drug order processing. A hearing is scheduled for Sept. 16, 2020, via teleconference.

Also in Georgia: The Office of Insurance and Safety Fire Commissioner issued a notice to announce Bulletin 21-EX-8 to specify that, when an audit of a pharmacy is conducted by a managed care company, insurance company, pharmacy benefits manager, or another payor, the final audit report must be delivered to the pharmacy within 90 days after receipt of the preliminary audit report or final appeal, whichever is later. Contact: Office of Insurance and Safety Fire Commissioner; 404-656-2056

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-05-21T09:50:13-04:00May 21, 2021|Georgia|

Iowa

Earlier this week, the House of Representatives and, subsequently, the Senate passed HF 891, an act relating to appropriations for health and human services, and it will be sent to the governor. The bill includes language directing the department to amend Medicaid managed care organization contracts to authorize the establishment of a managed care pharmacy dispensing fee reimbursement with either (a) the established fee-for-service $10.38 pharmacy dispensing fee reimbursement per prescription based upon the most recent state cost of dispensing study or (b) a dispensing fee determined contractually by mutual agreement between the managed care organization and a participating pharmacy with more than 30 locations in the state and headquarters outside the state, not to exceed the established fee-for-service $10.38 pharmacy dispensing fee reimbursement per prescription.

Also in Iowa, this week, Gov. Kim Reynolds (R) signed SF 296 into law authorizing pharmacists to order and administer COVID-19 immunizations or vaccinations to adults according to statewide protocols, perform point-of-care testing for influenza, streptococcus, and COVID-19 and initiate treatment following a positive test, and enter into collaborative practice agreements with other healthcare providers.

Lastly in Iowa, on May 10 the Board of Pharmacy issued guidance on how a pharmacy may report dispensations or transactions involving nonprescription Schedule V controlled substances, such as codeine-containing cough syrups, to the Iowa Prescription Monitoring Program, under an April 7 final rule.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-21T09:48:18-04:00May 21, 2021|Iowa|

Mississippi

The Division of Medicaid issued a proposed rule to amend regulations under Title 23, Part 224, Chapter 1 to set the fees for immunizations to those in effect for the state fiscal year 2021. Comments are due May 30, 2021. For more information please contact: Margaret Wilson; Division of Medicaid; 601-359-5248; Margaret.Wilson@medicaid.ms.gov

Also in Mississippi. The Division of Medicaid also issued a proposed rule to amend regulations under Title 23, Part 200, Chapters 1, 3, and 4 to increase the time for providers to request an administrative review for claims to 90 days. The rule also would revise beneficiary cost-sharing and 340B provider requirements to comply with federal standards. Comments are due May 30, 2021. For more information please contact: Margaret Wilson; Division of Medicaid; 601-359-5248; Margaret.Wilson@medicaid.ms.gov

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-05-21T09:45:25-04:00May 21, 2021|Mississippi|

Missouri

Last week, the Missouri Legislature passed legislation SB 63 establishing the framework for a statewide PDMP. Once operational, this new program will preempt any local PDMP program such as the one set up by St. Louis County that numerous other municipalities throughout the State of Missouri have opted to participate in. Initially, the statewide program will require pharmacies to report dispensing data for schedule II, III & IV controlled substance prescriptions into the PDMP every 24 hours, but the reporting timeframe will phase over to real-time reporting by 2024. The legislation next goes to the Governor to be signed into law. Once enacted, Missouri will become the last state in the nation to establish a PDMP.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

Michael Silber2021-05-21T09:37:00-04:00May 21, 2021|Missouri|

Nebraska

On May 5, 2021, Gov. Pete Ricketts (R) signed LB 583, requiring Schedule II-V controlled substances prescriptions to be electronically prescribed with exceptions effective January 1, 2022. However, dentists will be required to do so beginning January 1, 2024.

Also in Nebraska, the Department of Health and Human Services published the agenda for the next conference call meeting of the Board of Pharmacy on Monday, May 24, 2021. The March 22 conference call meeting minutes are also available.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-21T09:34:04-04:00May 21, 2021|Nebraska|

North Carolina

The Board of Pharmacy issued a proposed rule to amend and adopt regulations under 21 NCAC 46 to establish new requirements for limited-service permits for certain pharmacies where services are provided by pharmacist-managers serving multiple pharmacies. The rule also would allow pharmacist-managers to be present at limited-service permits for less time than at regular pharmacy permits, allow pharmacist-managers to designate an assistant pharmacy-manager for limited-service permits, and provide that pharmacist-managers do not need to personally package drugs dispensed by nurse practitioners or physician assistants, among other conforming changes. A hearing is scheduled for July 20, 2021, via webcast and teleconference. Comments are due July 20, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

Michael Silber2021-05-21T09:29:21-04:00May 21, 2021|North Carolina|

Oregon

The Board of Pharmacy published the following proposed rules with a deadline for comments on May 26, 2021. Also, hearings are scheduled for May 26, 2021, via teleconference.

Proposed rule amends regulations under OAR 855-007 to allow pharmacists at immunizing clinics to supervise as many state-licensed immunizing interns as they determine will maintain public health and safety during a declared public health emergency. The proposal, which is the response to the COVID-19 pandemic, currently is in effect as a temporary rule, expiring June 18, 2021.
Proposed rule amends and adopts regulations under OAR 855-019, -021, -025, and -031 to incorporate cultural competency continuing education requirements for pharmacists, pharmacy technicians, and pharmacy interns.
Proposed rule amends, adopts, and repeals regulations under OAR 855-080 to update the incorporation by reference to the federal controlled substance schedules and prescription requirements. The rule also would add provisions on persons who are exempt from controlled substances registration requirements and remove outdated provisions on verification of research registration and drug disposal.
Proposed rule amends regulations under OAR 855-041 to remove the limit on epinephrine dispensed to an entity to allow maintenance of epinephrine at coronavirus (COVID-19) vaccination locations. The proposal currently is in effect as a temporary rule, expiring Sept. 19, 2021.
Proposed rule amends regulations under OAR 855-041 to revise provisions on returned drugs and devices and on secure and responsible drug disposal to implement requirements for drug take-back programs. Note: Requirements for pharmacies that operate collections sites would be updated to include notifying the Board if they initiate or cease to operate such a program.
Proposed rule amends regulations under OAR 855-001 and -041 to revise requirements for inspection of drug outlets and pharmacy records. The rule would require records to be stored on-site for 12 months, require records to be provided to the board upon request, and allow for off-site storage after 12 months.
Proposed rule amends regulations under OAR 855-110 to revise the late fee expiration dates for licensees and registrants.
Proposed rule amends regulations under OAR 855-006 and repeals regulations under OAR 855-050 to remove outdated restrictions on retail drug sales and make a confirming change to incorporate the definition of “prescription drug.”
Proposed rule amends regulations under OAR 855-041, -043, and -044 to add requirements on information inserts for prescription drugs dispensed to limited English proficiency patients.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-21T09:28:29-04:00May 21, 2021|Oregon|

Pennsylvania

Gov. Wolf issued a revised waiver clarifying that pharmacists may administer the COVID vaccine to patients 12 years of age and above. As in previous versions of this waiver, it does not mention pharmacy technicians but does recognize the PREP act pre-emption.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

Michael Silber2021-05-21T09:27:23-04:00May 21, 2021|Pennsylvania|

Utah

The Department of Commerce issued a final rule to amend regulations under R156-17b to conform the rule to statutory changes made by S.B. 145, S.B.157, H.B. 24, and H.B. 207 passed during the 2020 General Session. These bills amended the Pharmacy Practice Act regarding dispensing scope of practice for pharmacist and pharmacy interns and changed the requirements for the charitable prescription drug recycling program. Additionally, the Division of Occupational and Professional Licensing in collaboration with the Board of Pharmacy recommends certain amendments to the preceptor language to reflect the current practice in the profession. The rule was effective March 11.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

Michael Silber2021-05-21T09:26:09-04:00May 21, 2021|Utah|